References
- Beresford A. P., MaCrae P. V., Stopher D. A. Metabolism of amlodipine in the rat and dog, a species difference. Xenobiotica 1988; 18: 169–182
- Guengerich F. P. Oxidative cleavage of carboxylic esters by cytochrome P-450. Journal of Biological Chemistry 1987; 262: 8459–8462
- Guengerich F. P., Bocker R. H. Cytochrome P-450-catalyzed dehydrogenation of 1,4-dihydropyridines. Journal of Biological Chemistry 1988a; 263: 8168–8175
- Guengerich F. P., Martin M. V., Beaune P. H., Kremers P., Wolff T., Waxman D. J. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. Journal of Biological Chemistry 1986; 261: 5051–5060
- Guengrich F. P., Peterson L. A., Bocker R. H. Cytochrome P-450-catalyzed hydroxylation and carboxylic acid ester cleavage of Hantzsch pyridine esters. Journal of Biological Chemistry 1988b; 263: 8176–8183
- Higuchi S., Sasaki Y., Shiobara Y., Sado T. Absorption, excretion and metabolism of a new dihydropyridine diester cerebral vasodilator in rats and dogs. Xenobiotica 1977; 7: 469–479
- Higuchi S., Shiobara Y. Metabolic fate of nicardipine hydrochloride, a new vasodilator, by various species in vitro. Xenobiotica 1980; 10: 889–896
- Kobayashi H., Okumura S., Kosaka Y., Kobayashi S., Inoue A., Oka T., Makamizo N. Identification of benidipine hydrochloride metabolites in rats and dogs. Arzneimittel-Forschung/Drug Research 1988; 38: 1753–1756
- Kondo S., Kuchiki A., Yamamoto K., Akimoto K., Takahashi K., Awata N., Sugimoto I. Identification of nifedipine metabolites and their determination by gas chromatography. Chemical & Pharmaceutical Bulletin 1980; 28: 1–7
- Meyer H., Scherling D., Karl W. Nitrendipine: identification and synthesis of main metabolites. Arzneimittel-Forschung/Drug Research 1983a; 33: 1528–1534
- Meyer H., Wehinger E., Bossert F., Scherling D. Nimodipine: Synthesis and metabolic pathway. Arzneimittel-Forschung/Drug Research 1983b; 33: 106–112
- Nelson D. R., Kamataki T., Waxman D. J., Guengerich F. P., Estabrook R. W., Feyereisen R., Gonzalez F. J., Coon M. J., Gunsalus I. C., Gotoh O., Okuda K., Nebert D. W. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA and Cell Biology 1993; 12: 1–51
- Niwa T., Tokuma Y., Noguchi H. Oxidation of nilvadipine, a new dihydropyridine calcium antagonist, to the corresponding pyridine by rat liver microsomes. Xenobiotica 1988; 18: 217–224
- Tamazawa K., Arima H., Kajima T., Isomura Y., Okada M., Fujita S., Furuya T., Takenaka T., Inagaki O., Terai M. Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate. Journal of Medical Chemistry 1986; 29: 2504–2511
- Teramura T., Kobayashi S., Higuchi S. Metabolism of barnidipine hydrochloride in rats, dogs and humans. Abstract published in Proceedings of the 5th European International Society for the Study of Xenobiotics Meeting, ToursFrance, 1993, 103, abstract
- Terashita S., Tokuma Y., Fujiwara T., Shiokawa Y., Okumura K., Noguchi H. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Xenobiotica 1987; 17: 1415–1425
- Triggle D. J. Calcium Blockers: Mechanism of action and clinical applications, S. F. Flaim, R. Zelis. Urban & Schwarzenberg, Baltimore 1982; 121
- Weidolf L., Borg K. O., Hoffman K. J. Urinary metabolites of felodipine, a new vasodilator drug, in man, rat and mouse. Xenobiotica 1984; 14: 657–666
- Yoshida K., Mitsuya M., Tsukamoto T., Hisaka H., Kobayashi T., Tanayama K. Metabolism of manidipine hydrochloride [CV-4093 (2HCl)], a new calcium antagonist, in rats and dogs. Japanese Pharmacology and Therapeutics 1989; 17: 249–265